中国医疗保险
中國醫療保險
중국의료보험
CHINA HEALTH INSURANCE
2013年
7期
56-58
,共3页
基本药物制度%问题%完善
基本藥物製度%問題%完善
기본약물제도%문제%완선
essential drug system%problems%improvement
基本药物制度是国家药品政策的核心和药品供应保障体系的基础，实施4年来，一定程度上缓解了国民“看病贵”的难题，并带来多方面的综合效果。但在理念共识、业务流程、质量监管、普及导向等方面仍存在一些问题，需要多方联动，全程监管，才能进一步巩固完善基本药物制度，让国民用上放心药。
基本藥物製度是國傢藥品政策的覈心和藥品供應保障體繫的基礎，實施4年來，一定程度上緩解瞭國民“看病貴”的難題，併帶來多方麵的綜閤效果。但在理唸共識、業務流程、質量鑑管、普及導嚮等方麵仍存在一些問題，需要多方聯動，全程鑑管，纔能進一步鞏固完善基本藥物製度，讓國民用上放心藥。
기본약물제도시국가약품정책적핵심화약품공응보장체계적기출，실시4년래，일정정도상완해료국민“간병귀”적난제，병대래다방면적종합효과。단재이념공식、업무류정、질량감관、보급도향등방면잉존재일사문제，수요다방련동，전정감관，재능진일보공고완선기본약물제도，양국민용상방심약。
Essential drugs system is the core of the national drug policy and the base of drug supply security system, during the past four years of its implementation, to some extent, it effectively alleviated people’s"expensive treatment" problem, bringing multifaceted complex effects. But there are still some problems in terms of concept consensus, business process, quality supervision, popularization and guidance. So it needs multi-linkage, full supervision, and further reinforce and improvement on the Essential Drug System, so as to let people access to safe medicines.
